Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Michael S. Wyzga is an American businessperson who founded Sporos Bioventures, Inc. and who has been the head of 8 different companies. Presently, he holds the position of Chairman of Gensight Biologics SA, Chairman at Mereo BioPharma Group Plc, Independent Chairman of X4 Pharmaceuticals, Inc., Chairman & Chief Financial Officer at Sporos Bioventures, Inc. and President at Bioleap, Inc. (Florida). Mr. Wyzga is also on the board of 5 other companies.

He previously held the position of President, Chief Executive Officer & Director at Radius Health, Inc., Chief Financial Officer of Aura Biosciences, Inc., Chief Financial Officer & Vice President at CacheLink Corp., Chief Financial Officer for Kew, Inc., Chairman at Arsanis, Inc., Chairman for X4 Pharmaceuticals, Inc., Vice President-Finance for Lotus Development Corp., Chief Financial Officer & Executive Vice President for Genzyme Corp., Chief Financial Officer at Sovereign Hill Software, Inc. and Principal at Digital Equipment Corp.

Michael S. Wyzga received an undergraduate degree from Suffolk University and an MBA from Providence College.


Current positions of Michael S. Wyzga 
NameTitle Since
Invivyd, Inc.
(Biotechnology & Medical Research)
Director 2021
GenSight Biologics S.A.
(Biotechnology & Medical Research)
Chairman 2016
X4 Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Independent Chairman 2018
Mereo BioPharma Group plc
(Biotechnology & Medical Research)
Chairman 2022
LogicBio Therapeutics, Inc.
(Pharmaceuticals)
Independent Director 2018
Bioleap, Inc. (Florida) Chief Financial Officer 2020
Sporos Bioventures, Inc. Chairman & Chief Financial Officer -
International Institute of New England, Inc. Director -
Dohmen Co. Director 2010
Tvardi Therapeutics, Inc. Director 2021


Holdings of Michael S. Wyzga 
NameEquities%Valuation
X4 Pharmaceuticals, Inc. (XFOR)
(Biotechnology & Medical Research)
6,6670.0097%6,600 USD
LogicBio Therapeutics, Inc. (LOGC)
(Pharmaceuticals)
3,1410.0095%1,124 USD


Michael S. Wyzga: Personal Network 
Most Read News 
09/13Ark's Cathie Wood calls Fed hikes a mistake and preps for deflation
RE
06:19aUnilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/14Package that exploded in Boston had note critical of Meta's Zuckerberg, CNN reports
RE
09/12Nikola founder Trevor Milton's U.S. trial to begin with jury selection
RE
09/13Inditex founder Amancio Ortega to buy U.S. warehouses for $905 million
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
06:14aTwitter to interview Elon Musk, known for combative testimony
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
More news


© 2022 People and Ownership :   
Michael S. Wyzga : Connections